Search Results 31-40 of 17308 for egfr

  1. Sacituzumab Tirumotecan (MK-2870) Versus Chemotherapy in Previously Treated Advanced or Metastatic Nonsquamous Non-small Cell Lung Cancer (NSCLC) With EGFR Mutations or Other Genomic Alterations (MK-2870-004) - Mayo Clinic

    Sacituzumab Tirumotecan (MK-2870) Versus Chemotherapy in Previously Treated Advanced or Metastatic Nonsquamous Non-small Cell Lung Cancer (NSCLC) With EGFR ...

  2. An Open-label Study Using ASP-1929 Photoimmunotherapy In Combination With Anti-PD1 Therapy In EGFR Expressing Advanced Solid Tumors - Mayo Clinic

    An Open-label Study Using ASP-1929 Photoimmunotherapy In Combination With Anti-PD1 Therapy In EGFR Expressing Advanced Solid Tumors. Print details. Share ...

  3. Amivantamab and hyaluronidase-lpuj (subcutaneous route) - Side effects & uses - Mayo Clinic

    ... (EGFR) gene (exon 19 deletions or exon 21 L858R substitution mutations). This medicine is also used in combination with carboplatin and pemetrexed to treat ...

  4. Mayo Clinic opens new doors in cancer treatment innovation

    These include human epidermal growth factor receptor 2 (HER2), epidermal growth factor receptor (EGFR), and mesenchymal-epithelial transition factor (MET).

  5. A Study To Evaluate The Safety And Efficacy Of A2B395, An Allogeneic Logic-gated CAR T, In Participants With Solid Tumors That Express EGFR And Have Lost HLA-A*02 Expression - Mayo Clinic

    A Study To Evaluate The Safety And Efficacy Of A2B395, An Allogeneic Logic-gated CAR T, In Participants With Solid Tumors That Express EGFR And Have Lost HLA-A* ...

  6. Atezolizumab (intravenous route) - Side effects & uses - Mayo Clinic

    ... EGFR or ALK gene. It is also used to treat metastatic non-small cell lung cancer with or without an EGFR or ALK gene in patients who have tried treatment for ...

  7. Hematology - Clinical trials

    Additional patients limited to those with EGFR mutations may be enrolled following the initial study period as needed to ensure adequate sample sizes needed to ...

  8. MRI: Is gadolinium safe for people with kidney problems? - Mayo Clinic

    Older versions of contrast agents that contain gadolinium increase the risk of a rare but serious disease called nephrogenic systemic fibrosis. This disease ...

  9. Study Of Ravulizumab In Immunoglobulin A Nephropathy (IgAN) - Mayo Clinic

    The primary objective of this study to evaluate efficacy of ravulizumab compared with placebo on proteinuria reduction and change in eGFR in adult participants ...

  10. Fluorescence in situ hybridization - Cytogenetics Core - Mayo Clinic Research

    Determine the presence or absence of interspecies cells in xenograft or chimeric animal models. Fluorescence in situ hybridization of a locus-specific EGFR ...